Following $105M raise, St. Louis biotech startup Arch Oncology adds 3 execs to C-suite
August 03, 2021 at 14:02 PM EDT
The St. Louis biotech startup has bolstered its medical and clinical leadership as the company advances development of its lead drug candidate.
